pillbase.ru

GUNA-SLEEP

Active substance: AVENA SATIVA FLOWERING TOP, CHAMOMILE, HELLEBORUS NIGER ROOT, STRYCHNOS IGNATII SEED, CANAKINUMAB, MELATONIN, MELISSA OFFICINALIS, SUS SCROFA PINEAL GLAND, PULSATILLA VULGARIS, SEROTONIN, VALERIAN

SOLUTION/ DROPS · AVENA SATIVA FLOWERING TOP 6 [hp_C]/30mL, CHAMOMILE 6 [hp_C]/30mL, HELLEBORUS NIGER ROOT 6 [hp_C]/30mL, STRYCHNOS IGNATII SEED 6 [hp_C]/30mL, CANAKINUMAB 4 [hp_C]/30mL, MELATONIN 4 [hp_C]/30mL, MELISSA OFFICINALIS 6 [hp_C]/30mL, SUS SCROFA PINEAL GLAND 12 [hp_X]/30mL, PULSATILLA VULGARIS 6 [hp_C]/30mL, SEROTONIN 6 [hp_C]/30mL, VALERIAN 6 [hp_C]/30mL

United StatesActive

Marketing holder: Guna spa

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
  • AVENA SATIVA FLOWERING TOP · 6 [hp_C]/30mL
  • CHAMOMILE · 6 [hp_C]/30mL
  • HELLEBORUS NIGER ROOT · 6 [hp_C]/30mL
  • STRYCHNOS IGNATII SEED · 6 [hp_C]/30mL
  • CANAKINUMAB · 4 [hp_C]/30mL
  • MELATONIN · 4 [hp_C]/30mL
  • MELISSA OFFICINALIS · 6 [hp_C]/30mL
  • SUS SCROFA PINEAL GLAND · 12 [hp_X]/30mL
  • PULSATILLA VULGARIS · 6 [hp_C]/30mL
  • SEROTONIN · 6 [hp_C]/30mL
  • VALERIAN · 6 [hp_C]/30mL
Products containing canakinumab in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

CountryProducts
RU 5
  • Иларис®
    раствор для подкожного введения, 150 мг/мл, 1 мл (original in Russian, GRLS)
    ЛП-№(003003)-(РГ-RU)
    Новартис Фарма АГ
  • Иларис®
    раствор для подкожного введения, 150 мг/мл, 1 мл (original in Russian, GRLS)
    ЛП-005320
    Новартис Фарма АГ
  • Лимирис®
    лиофилизат для приготовления раствора для подкожного введения, 150 мг, 150 мг (original in Russian, GRLS)
    ЛП-№(011479)-(РГ-RU)
    Акционерное общество "ГЕНЕРИУМ" (АО "ГЕНЕРИУМ")
  • Лимирис®
    раствор для подкожного введения, 150 мг/мл, 1 мл (original in Russian, GRLS)
    ЛП-№(012816)-(РГ-RU)
    Акционерное общество "ГЕНЕРИУМ" (АО "ГЕНЕРИУМ")
  • Иларис®
    лиофилизат для приготовления раствора для подкожного введения, 150 мг, 150 мг (original in Russian, GRLS)
    ЛП-001414
    Новартис Фарма АГ
EU 2
  • Canakinumab Novartis
    canakinumab
    EMEA/H/C/004754
    Novartis Europharm Limited
  • Ilaris
    canakinumab
    EMEA/H/C/001109
    Novartis Europharm Limited
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-4f7e-74eb-bd6c-dc528d91771f,01a120c3-c3c1-7606-8729-b1fdf371323b,01a120c3-d0ce-7694-a564-82e4674b5d15,01a120c5-06bb-75cf-b7bb-7573f5005210,01a120c5-cd73-70c2-a282-0c5c50efe76d;count=5 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208e-01bc-7c70-ad9d-8f145a67b79d,01a12093-3c1d-7a72-aad4-ec34efbbf77d;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
17089-294
Registration status
Active
Dispensing
Over the counter
Route
ORAL
Sources
  • product · openFDA NDC · 17089-294 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 17089-294 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 17089-294 · Verified 2026-10-09 · open in source
  • ingredients.1 · openFDA NDC · 17089-294 · Verified 2026-10-09 · open in source
  • ingredients.2 · openFDA NDC · 17089-294 · Verified 2026-10-09 · open in source
  • ingredients.3 · openFDA NDC · 17089-294 · Verified 2026-10-09 · open in source
  • ingredients.4 · openFDA NDC · 17089-294 · Verified 2026-10-09 · open in source
  • ingredients.5 · openFDA NDC · 17089-294 · Verified 2026-10-09 · open in source
  • ingredients.6 · openFDA NDC · 17089-294 · Verified 2026-10-09 · open in source
  • ingredients.7 · openFDA NDC · 17089-294 · Verified 2026-10-09 · open in source
  • ingredients.8 · openFDA NDC · 17089-294 · Verified 2026-10-09 · open in source
  • ingredients.9 · openFDA NDC · 17089-294 · Verified 2026-10-09 · open in source
  • ingredients.10 · openFDA NDC · 17089-294 · Verified 2026-10-09 · open in source